4G Clinical, a Boston, MA-based randomization and trial supply management company, secured $2.5M in Series A funding.
The round was led by Boston-based Schooner Capital.
The company will use the funds to build out its business and technology offering, to continue to recruit talent, and to promote the brand at industry conferences.
Led by Dave Kelleher, CEO, and Ed Tourtellotte, CTO, 4G Clinical provides a randomization and trial supply management platform supporting global Phase 2 and 3 clinical trials.
FinSMEs
29/01/2016